Weyerhaeuser Co: Form 10-K for the period ended Dec 31, 2025
Filed with the SEC on Feb 13, 2026 and accepted by EDGAR at Feb 13, 2026, 16:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $6.91bn | us-gaap:Revenues |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $5.88bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $1.02bn | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $5.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $731.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $273.0m | us-gaap:InterestExpense |
| Income tax | 12 months2025-01-01 to 2025-12-31 | −$64.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | $324.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $0.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $0.45 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 723,567,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $562.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2025-01-01 to 2025-12-31 | $606.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2025-01-01 to 2025-12-31 | $160.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $464.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $1.65bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $16.61bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $1.28bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $7.19bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $5.05bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-12-31 | $522.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $9.43bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-26-051422. Last ingested by Listed: Oct 29, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.